Diabetes

A 2-drug combination reduced retinal cell death more effectively than a single drug therapy.

Diabetes management cost the United States an estimated $245 billion in 2012, including $176 billion for direct treatment and complications.

Advocacy group warns that American Health Care Act may harm patients with diabetes.

Sustained and controllable insulin delivery may improve diabetes care.

Long-term metformin therapy associated with lower serum vitamin B12 concentration.

Patients with type 2 diabetes administered long-term metformin more likely not to have vitamin B12 levels monitored.

African Americans with sickle cell trait may have inaccurate HbA1c test results.

The TrpC5 ion channel is necessary for appetite suppression regulated by leptin or lorcaserin.

New research conducted by the London Metropolitan University suggests that patients may be able to follow a reduced carb diet as an effective and safe strategy for managing their diabetes.

New treatment approach harnesses the abilty of liver cells to burn accumulated fats.

Certain beta cells are able to evade an immune system attack in type 1 diabetes.

A collaborative clinic could save more than $5000 per patient over 3 years.

Genetics that determine physical traits may play a large role in prevalence of conditions such as multiple sclerosis, autism, and diabetes.

This article will highlight several key therapeutics areas with lixisenatide that every pharmacist should know.

The first of 4 new clinical trial of artificial pancreas systems has begun, which could benefit patients with type 2 diabetes.

Chronic exposure to air pollution may have a wide-reaching impact on children’s health.

Young individuals with type 2 diabetes are more likely to develop condition-related complications than their type 1 counterparts.

Liraglutide reduced the risk of type 2 diabetes by 80%.

Senior Executives with Insulet Corporation recently announced their milestone of achieving 100,000 active users worldwide of the Omnipod® Insulin Management System.

Some patients may not benefit from strict blood sugar control.

When patients are diagnosed with type 2 diabetes, clinicians stress lifestyle modifications—and especially diet—as the first and best intervention.

Patients with type 2 diabetes more likely to experience signs of kidney, nerve, and eye diseases.

Improved blood glucose control was elicited from the transplantation of reprogrammed pancreatic cells.

MiniMed 670G significantly reduced HbA1c levels in adolescents and adults with type 1 diabetes.

Fixed-dose combination provides another oral treatment option for patients with diabetes.